NCT07163936View on ClinicalTrials.gov

Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Disease Undergoing Hemodialysis

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 3, 2025

Primary Completion Date

September 6, 2026

Study Completion Date

September 6, 2026

Conditions
Vascular CalcificationHemodialysisCardiovascular Disease (CKD)
Interventions
DEVICE

Citrate dialysate with magensium supplementation

Citrate-based bicarbonate dialysate containing: sodium 138 mmol/L, chloride 110 mmol/L, potassium 2 mmol/L, calcium 1.5 mmol/L, magnesium 0.75 mmol/L, citrate 1 mmol/L, glucose 1 g/L, bicarbonate 32 mmol/L.

DEVICE

Acetate dialysate

Acetate-based bicarbonate dialysate containing: sodium 138 mmol/L, chloride 109 mmol/L, potassium 2 mmol/L, calcium 1.5 mmol/L, magnesium 0.5 mmol/L, acetate 3 mmol/L, glucose 1 g/L, bicarbonate 32 mmol/L.

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER